These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8148225)

  • 1. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin.
    Lehto P; Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):82-5. PubMed ID: 8148225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic drug monitoring of fluoroquinolone].
    Matsumoto F; Takahashi T; Morita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of sucralfate on absorption of norfloxacin and ofloxacin.
    Lehto P; Kivistö KT
    Antimicrob Agents Chemother; 1994 Feb; 38(2):248-51. PubMed ID: 8192452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ascorbic acid on interactions between ciprofloxacin and ferrous sulphate, sodium ferrous citrate or ferric pyrophosphate, in mice.
    Motoya T; Miyashita M; Kawachi A; Yamada K
    J Pharm Pharmacol; 2000 Apr; 52(4):397-401. PubMed ID: 10813549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humours of patients by different topical application modes.
    von Keyserlingk J; Beck R; Fischer U; Hehl EM; Guthoff R; Drewelow B
    Eur J Clin Pharmacol; 1997; 53(3-4):251-5. PubMed ID: 9476040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of 4-fluoroquinolones permeation into saliva.
    Kozjek F; Suturkova LJ; Antolic G; Grabnar I; Mrhar A
    Biopharm Drug Dispos; 1999 May; 20(4):183-91. PubMed ID: 10440793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
    Zeiler HJ; Beermann D; Wingender W; Förster D; Schacht P
    Infection; 1988; 16 Suppl 1():S19-23. PubMed ID: 3286510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor.
    Donnenfeld ED; Schrier A; Perry HD; Aulicino T; Gombert ME; Snyder R
    Ophthalmology; 1994 May; 101(5):902-5. PubMed ID: 8190478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC determination of enoxacin, ciprofloxacin, norfloxacin and ofloxacin with photoinduced fluorimetric (PIF) detection and multiemission scanning: application to urine and serum.
    Espinosa-Mansilla A; Peña AM; Gómez DG; Salinas F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):185-93. PubMed ID: 16006203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.
    Diamond JP; White L; Leeming JP; Bing Hoh H; Easty DL
    Br J Ophthalmol; 1995 Jun; 79(6):606-9. PubMed ID: 7626579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.
    Polk RE; Healy DP; Sahai J; Drwal L; Racht E
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1841-4. PubMed ID: 2610494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the influence of Ca2+ on absorption parameters of ciprofloxacin and ofloxacin.
    Sánchez Navarro A; Martínez Cabarga M; Dominguez-Gil Hurlé A
    J Antimicrob Chemother; 1994 Jul; 34(1):119-25. PubMed ID: 7961198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary pharmacodynamics of low-dose ciprofloxacin and ofloxacin.
    Stein GE; Schooley S; McMillan J
    Diagn Microbiol Infect Dis; 1998 Apr; 30(4):261-5. PubMed ID: 9582586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics.
    Akerele JO; Okhamafe AO
    J Antimicrob Chemother; 1991 Jul; 28(1):87-94. PubMed ID: 1663108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and chemical interactions between iron preparations and ciprofloxacin.
    Kara M; Hasinoff BB; McKay DW; Campbell NR
    Br J Clin Pharmacol; 1991 Mar; 31(3):257-61. PubMed ID: 2054264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.